TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS
6.1. Overview
6.2. Retinoids
6.3. Antibiotics
6.4. Salicylic Acid
6.5. Benzoyl Peroxide
6.6. Others
7. GLOBAL ACNE MEDICATION MARKET, BY FORMULATION
7.1. Overview
7.2. Topical Medications
7.3. Oral Medications
8. GLOBAL ACNE MEDICATION MARKET, BY TYPE
8.1. Overview
8.2. Prescription Medicines
8.3. Over-The-Counter Medicines
9. GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE
9.1. Overview
9.2. Non-Inflammatory Acne
9.3. Inflammatory Acne
10. GLOBAL ACNE MEDICATION MARKET, BY DISTRIBUTION CHANNEL
10.1. Overview
10.2. Retail Stores
10.3. Pharmacies & Drug Stores
10.4. E-Commerce
11. GLOBAL ACNE MEDICATION MARKET, BY REGION
11.1. Overview
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global acne medication Market,
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Global acne medication Market,
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2022
12.8.2. Major Players R&D Expenditure. 2022
13. COMPANY PROFILES
13.1. JOHNSON & JOHNSON
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. MYLAN N.V.
13.2.1. Company Overview
13.2.2. Financial Overview
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. PFIZER INC.
13.3.1. Company Overview
13.3.2. Financial Overview
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. BAUSCH HEALTH COMPANIES INC.
13.4.1. Company Overview
13.4.2. Financial Overview
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. MAYNE PHARMA GROUP LIMITED
13.5.1. Company Overview
13.5.2. Financial Overview
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. SUN PHARMACEUTICAL INDUSTRIES LIMITED
13.6.1. Company Overview
13.6.2. Financial Overview
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. ALMIRALL SA
13.7.1. Company Overview
13.7.2. Financial Overview
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. GALDERMA S.A.
13.8.1. Company Overview
13.8.2. Financial Overview
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
13.9.1. Company Overview
13.9.2. Financial Overview
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. GLAXOSMITHKLINE PLC (GSK)
13.10.1. Company Overview
13.10.2. Financial Overview
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
13.11. Brunswick Corporation
13.11.1. Company Overview
13.11.2. Financial Overview
13.11.3. Products Offered
13.11.4. Key Developments
13.11.5. SWOT Analysis
13.11.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ACNE MEDICATION MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL ACNE MEDICATION MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 11 US: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 12 US: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 13 US: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 14 US: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 15 CANADA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 16 CANADA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 17 CANADA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 18 CANADA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 4 EUROPE: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 7 GERMANY: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 8 GERMANY: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 10 FRANCE: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 11 FRANCE: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 12 FRANCE: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 13 ITALY: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 14 ITALY: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 15 ITALY: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 16 ITALY: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 17 SPAIN: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 18 SPAIN: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 19 SPAIN: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 20 SPAIN: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 21 UK: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 22 UK: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 23 UK: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 24 UK: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 33 JAPAN: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 34 JAPAN: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 35 JAPAN: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 36 JAPAN: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 37 CHINA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 38 CHINA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 39 CHINA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 40 CHINA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 41 INDIA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 42 INDIA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 43 INDIA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 44 INDIA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 45 AUSTRALIA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 46 AUSTRALIA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 47 AUSTRALIA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 48 AUSTRALIA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 65 AFRICA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 66 AFRICA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 67 AFRICA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 68 AFRICA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: ACNE MEDICATION MARKET, BY THERAPEUTIC CLASS, 2018-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: ACNE MEDICATION MARKET, BY FORMULATION, 2018-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: ACNE MEDICATION MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: ACNE MEDICATION MARKET, BY ACNE TYPE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ACNE MEDICATION MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ACNE MEDICATION MARKET
FIGURE 4 GLOBAL ACNE MEDICATION MARKET, SHARE (%), BY THERAPEUTIC CLASS, 2022
FIGURE 5 GLOBAL ACNE MEDICATION MARKET, SHARE (%), BY FORMULATION, 2022
FIGURE 6 GLOBAL ACNE MEDICATION MARKET, SHARE (%), BY TYPE, 2022
FIGURE 7 GLOBAL ACNE MEDICATION MARKET, SHARE (%), BY ACNE TYPE, 2022
FIGURE 8 GLOBAL ACNE MEDICATION MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: ACNE MEDICATION MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: ACNE MEDICATION MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: ACNE MEDICATION MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: ACNE MEDICATION MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL ACNE MEDICATION MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 GLAXOSMITHKLINE PLC (GSK): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 GLAXOSMITHKLINE PLC (GSK): SWOT ANALYSIS
FIGURE 16 MYLAN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 MYLAN N.V.: SWOT ANALYSIS
FIGURE 18 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS
FIGURE 20 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 PFIZER INC.: SWOT ANALYSIS
FIGURE 22 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 24 SUN PHARMACEUTICAL INDUSTRIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 SUN PHARMACEUTICAL INDUSTRIES LIMITED: SWOT ANALYSIS
FIGURE 26 ALMIRALL SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ALMIRALL SA: SWOT ANALYSIS
FIGURE 28 GALDERMA S.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 GALDERMA S.A.: SWOT ANALYSIS
FIGURE 30 MAYNE PHARMA GROUP LIMITED: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MAYNE PHARMA GROUP LIMITED: SWOT ANALYSIS
FIGURE 32 BRUNSWICK CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 BRUNSWICK CORPORATION: SWOT ANALYSIS
